The diversity of p53 mutations among human brain tumors and their functional consequences

Neurochemistry International

Volumn 40, Issue 7, 2002, Pages 637-645

  Zupanska, Agata ^a   Kaminska, Bozena ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Brain tumor therapy; Human brain tumors; p53 gene

Indexed keywords

CYCLOSPORIN A; FAS ANTIGEN; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

ADENOVIRUS; ARTICLE; BRAIN TUMOR; CANCER THERAPY; CODON; GENE ACTIVATION; GENE ACTIVITY; GENE DELETION; GENE TRANSFER; GERM LINE; GLIOBLASTOMA; HUMAN; MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRESS; VIRAL GENE THERAPY;

BRAIN NEOPLASMS; GENES, P53; HUMANS; MUTATION;

ADENOVIRIDAE;

EID: 0036129657     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00114-0     Document Type: Article

References (66)

1. Heterogeneity of subcellular localization of p53 protein in human glioblastomas
2. Signaling to p53: Breaking the post-translational modification code
3. The p53 gene and its role in human brain tumors
4. Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability
5. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
6. Cell cycle. Piecing together the p53 puzzle
7. Functional analyses of a unique p53 germline mutant (Y236delta) associated with a familial brain tumor syndrome
8. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
9. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
10. Pharmacological rescue of mutant p53 conformation and function
11. The p53 protein is an unusually shaped tetramer that binds directly to DNA
12. MEKK1/JNK signaling stabilizes and activates p53
13. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling
14. Conformational phenotype of 53 is linked to nuclear translocation
15. Protein synthesis required to anchor a mutant p53 protein, which is temperature-sensitive for nuclear transport
16. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis
17. Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas
18. Interaction of heat shock protein 70 with p53 translated in vitro: Evidence for interaction with dimeric p53 and for role in the regulation of p53 conformation
19. p53 transdominance but no gain of function in mouse brain tumor model
20. Expression and functional activity of heat shock proteins in human glioblastoma multiforme
21. IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell lines
22. Adenovirus-mediated wild-type p53 gene transfer and over-expression induces apoptosis of human glioma cells independent of endogenous p53 status
23. Immunological, molecular evidence for the association of p53 with a heat shock protein hsc70, in p53-plus-ras-transformed cell lines
24. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells. A comparison of the "hot spot" mutant phenotypes
25. Allosteric activation of latent p53 tetramers
26. Strategies for manipulating the p53 pathway in the treatment of human cancer
27. Profile of gene expression regulated by induced p53: Connection to the TGF-beta family
28. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappa B and Myc/Max
29. Reduced latency but no increased brain tumor penetrance in mice with astrocyte-specific expression of a human p53 mutant
30. Tumors associated with p53 germline mutations. A synopsis of 91 families
31. Germline p53 gene mutations in subsets of glioma patients
32. Characterization of the p53 gene
33. Adenovirus-mediated p53 gene therapy for human gliomas
34. The p53 gene and protein in human brain tumors
35. Familial brain tumor syndrome associated with a p53 germline deletion of codon 236
36. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein
37. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
38. Co-translation of activated mutant p53 with wild-type drives the wild-type p53 protein into the mutant conformation
39. The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
40. Biochemical properties of the growth suppressor/oncoprotein p53
41. Cyclosporin A, an immunosupressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor
42. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
43. The DNA binding domain of p53 contains the four conserved regions and the major mutation hot spots
44. Genetic profile of the giant cell glioblastoma
45. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin
46. A model for p53-induced apoptosis
47. Transcriptional regulation of the p53 tumor supressor gene
48. Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1
49. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53
50. Effect of phosphorylation on tetramerization of the tumor suppressor protein p53
51. DNA damage activates p53 through a phosphorylation-acetylation cascade
52. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques
53. Aberrant regulation and function of wild-type p53 in radio-resistant melanoma cells
54. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways
55. Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas
56. DNA damage, genes induces phosphorylation of the amino terminus of p53
57. Amplification and over-expression of mdm2 gene in ependynomas
58. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
59. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
60. p53 function and dysfunction
61. Surfing the p53 network
62. NIH 3T3 cells malignantly transformed by mot-2 show inactivation and cytoplasmic sequestration of the p53 protein
63. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function
64. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
65. Wild-type p53-dependent etopside-induced apoptosis-mediated by caspase-3 activation in human glioma cells
66. Identification and classification of p53-regulated genes